Overview

Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the association of bevacizumab and PDT is safety and effective in the treatment of exudative AMD
Phase:
Phase 2
Details
Lead Sponsor:
Federal University of São Paulo
Treatments:
Bevacizumab